the bronchoconstriction induced by histamine and specific recommendations exist for withholding these medications before bronchoprovocation testing.-4 There are no specific guidelines, however, for caffeine intake before testing.
the bronchoconstriction induced by histamine and specific recommendations exist for withholding these medications before bronchoprovocation testing. -4 There are no specific guidelines, however, for caffeine intake before testing.
The purpose of this investigation was to study whether caffeine at a dose of 5 mg/kg (about 3 cups of coffee) would alter histamine reactivity in adults with mild bronchial asthma. We chose this dose because the average caffeine content in a cup of coffee is about 150 mg and only 1900 of the population have more than three cups a day.' 8 
Methods

SUBJECTS
We studied 10 symptom free asthmatic subjects (seven male) with a mean age of 46 (SD 17) years. Nine subjects had previously documented increased airway reactivity (a provocative concentration of histamine causing a 20% fall in FEV, (PC20) less than 8 mg/ ml), and the other had a history of seasonal asthma and a PC20 of less than 16 mg/ml. Before the study seven subjects used an inhaled beta agonist, five theophylline and four an inhaled corticosteroid; two required no medication. The four patients taking inhaled steroids (Nos 2, 5, 7, 8 The subjects were randomised to receive caffeine and placebo first in a double blind crossover study. The study was carried out at fig 1) ; both values were 84% ofthe predicted FEVy.7 Mean (SD) FEVy increased by 0 10 (0 09) 1 after caffeine compared with 0 05 (0 06) after placebo (p = 0 38). The mean (SD) serum caffeine concentration was ((1 -23) Mg/ml after caffeine; none was detected after placebo (table). Theophylline was not detected in the serum of any patient on either study day.
Caffeine
All subjects had a PC20 of 16 mg/ml or less Caffeine after both caffeine and placebo. There was no significant difference in PC20 values or in the slope of the dose-response relationship between caffeine and placebo (table and fig 1) . The PC20 increased by more than two dose concentrations in two subjects after caffeine and decreased by two dose concentrations in one (fig 1) . There was no relation between serum caffeine concentrations and change in PC20 (table) . The two subjects showing the greatest increase in PC20 had the highest (6-66 Mg/ml) and lowest (2-50 ug/ml) caffeine concentrations (table) .
Discussion
We have shown that caffeine, in a dose that produced a mean serum caffeine concentration of 5 4 pg/ml, did not substantially alter airway reactivity in a group of symptom free asthmatic subjects and caused no significant bronchodilatation. The effect of dietary consumption of caffeine on histamine responsiveness has not been examined previously. A recent epidemiological study suggested that caffeine may suppress symptoms to such a degree that the clinical diagnosis of asthma is prevented.' We wondered whether caffeine might also alter the result of bronchoprovocation testing. Our results suggest that caffeine is not likely to have a large effect on the response to histamine challenge and prior intake of moderate amounts of caffeine is unlikely to be important in epidemiological or clinical studies using bronchoprovocation. It is not surprising that caffeine does not protect against histamine or carbachol bronchoprovocation whereas theophylline may have this effect. Caffeine is only 400/, as active as an equivalent molar dose of theophylline.8 Moreover, the protective effect of theophylline has not been consistent.39 In studies where an effect has been seen the protection was dose dependent and was greatest in subjects with the lowest PC2.3"o"" It is therefore possible that higher doses of caffeine given to more reactive asthmatic patients might afford some protection. The dose of caffeine would be greater however than that usually consumed by most individuals. ' Possibly a "time" error accounts for the lack of difference noted in this study. Peak caffeine concentrations are seen 45-60 minutes after ingestion8 1213 and the serum concentration does not fall for at least another 30 minutes.'2 Bronchodilatation when it occurs is maximal 120 minutes after ingestion.8 13 As we measured PC20 at 120 minutes we are unlikely to have missed the peak effect of caffeine on PC20.
In conclusion, caffeine in dietary concentrations is unlikely to have an effect on the results of histamine bronchoprovocation in those with mild asthma. Specific instructions on caffeine intake are not necessary before bronchoprovocation testing.
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